Infectious Disease and Microbiology – Sporotrichosis

Sporotrichosis is a dimorphic fungal infection caused by Sporothrix schenckii complex organisms. It most often develops after traumatic inoculation of the fungus into the skin and classically appears as lymphocutaneous disease, although fixed cutaneous, disseminated cutaneous, pulmonary, osteoarticular, and systemic forms can also occur.

The infection is particularly associated with tropical and subtropical regions of the Americas, although sporotrichosis occurs worldwide. Environmental exposure to contaminated soil, plants, rose bushes, sphagnum moss, hay, timber, and other vegetation can lead to inoculation through minor skin injuries.

Zoonotic transmission is also recognized. Infection has been associated with several animals, but cats are an especially important source of human sporotrichosis, particularly when infected animals have ulcerated skin lesions containing large numbers of organisms.

People with frequent outdoor or occupational exposure are at greater risk, including farmers, gardeners, florists, horticultural workers, forestry workers, miners, and veterinarians.

Disseminated or extracutaneous disease is uncommon and occurs mainly in people with impaired host defenses. Important predisposing conditions include advanced HIV infection, chronic corticosteroid therapy, chemotherapy, alcoholism, diabetes mellitus, and chronic pulmonary disease.

Sporothrix is a thermally dimorphic fungus. In the environment and at room temperature, it grows as a mold with branching hyphae, while in human tissue it is found primarily in a yeast form.

The yeast forms are generally small and may appear elongated or cigar-shaped. Because the fungal burden in tissue can be low, organisms are often difficult to identify directly on routine microscopy.

The incubation period after inoculation is usually approximately 1–12 weeks.

The first lesion generally appears as a small painless papule at the site of inoculation. It may gradually enlarge, become reddish or violaceous, develop into a pustule or nodule, and eventually ulcerate with a small amount of serous or serosanguineous drainage.

The lesion is usually not very tender. Significant pain can suggest secondary bacterial infection or an alternative diagnosis.

In lymphocutaneous sporotrichosis, secondary nodules develop progressively along the lymphatic vessels draining the original lesion. This produces the classic ascending chain of subcutaneous nodules.

This characteristic pattern is often described as sporotrichoid lymphatic spread.

A useful clinical sequence is:

Skin trauma involving vegetation or an infected cat → painless papule → ulceration → additional nodules ascending along lymphatic channels.

In fixed cutaneous sporotrichosis, the infection remains localized to the original inoculation site without lymphatic spread. The lesion can persist for prolonged periods if untreated.

Disseminated cutaneous sporotrichosis produces multiple papules, nodules, or ulcers at noncontiguous sites. This presentation should raise concern for an underlying immunocompromising condition and possible systemic dissemination.

Osteoarticular disease may involve joints, bones, or both. Patients can develop a slowly progressive chronic monoarthritis or oligoarthritis, with swelling, pain during movement, and progressive loss of function.

Long-standing osteoarticular disease may produce osteomyelitis, joint destruction, or draining sinus tracts.

Pulmonary sporotrichosis usually results from inhalation of fungal conidia rather than direct skin inoculation. It is uncommon and tends to occur in patients with underlying chronic lung disease or heavy alcohol use.

Pulmonary disease can resemble tuberculosis, with chronic cough, constitutional symptoms, upper-lobe abnormalities, cavitary lesions, and progressive pulmonary destruction.

Severely immunocompromised patients may develop disseminated sporotrichosis, with involvement of skin, joints, bones, lungs, and occasionally the central nervous system.

Sporothrix meningitis is rare but can occur, particularly in patients with significant immunosuppression. It usually requires prolonged antifungal therapy.

Diagnosis

The most reliable diagnostic method is fungal culture of material obtained from an affected site.

Appropriate specimens may include skin biopsy tissue, lesion drainage, synovial fluid, bone specimens, respiratory secretions, or cerebrospinal fluid, depending on the clinical presentation.

Culture should include fungal media such as Sabouraud dextrose agar. Growth of the mold form followed by appropriate identification establishes the diagnosis.

Histopathology can demonstrate granulomatous and suppurative inflammation, but fungal organisms are often sparse.

Special stains such as periodic acid–Schiff (PAS) and Gomori methenamine silver (GMS) can improve visualization of fungal elements.

The organisms in tissue may appear as small oval or cigar-shaped yeasts, usually measuring only a few micrometers.

An asteroid body, consisting of a yeast surrounded by eosinophilic material, can occasionally be seen histologically. It is suggestive but not diagnostic of sporotrichosis.

Because of the low organism burden, multiple biopsies or cultures may occasionally be required before the infection is confirmed.

There is no routinely accepted serologic test that reliably establishes the diagnosis in typical cutaneous disease.

Differential Diagnosis

The differential diagnosis of lymphocutaneous sporotrichosis includes other infections producing nodules along lymphatic channels, especially:

Mycobacterium marinum

Nontuberculous mycobacteria

Nocardia species

Cutaneous leishmaniasis

Tularemia

and selected bacterial skin infections.

Pulmonary sporotrichosis may resemble tuberculosis, nontuberculous mycobacterial infection, histoplasmosis, coccidioidomycosis, chronic bacterial lung infection, sarcoidosis, or malignancy.

Treatment

Itraconazole is the preferred first-line therapy for uncomplicated lymphocutaneous and fixed cutaneous sporotrichosis.

Treatment generally continues for several months and should usually extend beyond complete clinical resolution of lesions to reduce the risk of relapse.

Because itraconazole absorption can vary considerably, therapeutic drug monitoring may be useful in prolonged, severe, or treatment-refractory infection.

Terbinafine can be considered as an alternative for uncomplicated cutaneous disease when itraconazole cannot be used.

Historically, saturated solution of potassium iodide (SSKI) was widely used and can still be effective for cutaneous sporotrichosis.

Potassium iodide therapy is usually started at a low dose and gradually increased. Important adverse effects include nausea, rash, salivary-gland enlargement, excessive lacrimation, and symptoms of iodism.

Fluconazole is generally less effective than itraconazole, while voriconazole has poor activity against Sporothrix and is not considered a preferred treatment.

Local heat therapy has occasionally been used for limited cutaneous disease because Sporothrix grows poorly at higher temperatures, although systemic antifungal therapy remains preferable for established infection.

Osteoarticular sporotrichosis requires prolonged antifungal therapy, commonly with itraconazole for many months and sometimes approaching one year.

Patients with extensive joint destruction or osteomyelitis may require orthopedic consultation and surgical management.

Severe pulmonary, disseminated, or life-threatening sporotrichosis is generally treated initially with intravenous liposomal amphotericin B.

Once substantial clinical improvement occurs, therapy can usually be changed to itraconazole for prolonged consolidation treatment.

Central nervous system disease also generally requires initial treatment with amphotericin B followed by prolonged azole therapy.

Whenever possible, underlying immunosuppression should be reduced or corrected.

Prevention

Prevention focuses on reducing traumatic inoculation. Protective gloves, long sleeves, and appropriate footwear should be used when handling soil, plants, wood, hay, or other potentially contaminated material.

Skin injuries sustained during outdoor work should be cleaned promptly.

People handling cats with suspected sporotrichosis should use gloves and protective clothing, particularly when touching ulcerated lesions or contaminated secretions.

Prognosis

Localized cutaneous and lymphocutaneous sporotrichosis generally have an excellent prognosis when appropriately treated.

The outlook is less favorable in pulmonary, disseminated, osteoarticular, and CNS disease, particularly in patients with severe immunosuppression.

Important complications include chronic arthritis, osteomyelitis, progressive pulmonary disease, disseminated infection, and meningitis.

High-Yield Summary

Rose thorn / gardening / soil / infected cat exposure → painless skin papule → ulceration → ascending lymphatic nodules = sporotrichosis.

Diagnosis → fungal culture, often supported by biopsy with PAS or GMS staining.

Localized cutaneous disease → itraconazole.

Severe disseminated or CNS disease → amphotericin B initially, followed by prolonged itraconazole.